A doença cardiovascular é a causa número um de morte em todo mundo, responsável por uma estimativa de 17.9 milhões de mortes por ano.[6]World Health Organization. Cardiovascular diseases (CVDs). 2021 [internet publication].
https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
A mortalidade por doença coronariana tem diminuído em muitos países desenvolvidos, mas está aumentando em países em desenvolvimento e transicionais, em parte como resultado das mudanças de estilo de vida, da urbanização e do aumento da expectativa de vida. Nos EUA, estima-se que >780,000 pessoas apresentarão uma síndrome coronariana aguda por ano, e aproximadamente 70% delas apresentarão IAMSSST.[2]Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Dec 23;64(24):e139-228.
http://www.onlinejacc.org/content/64/24/e139
http://www.ncbi.nlm.nih.gov/pubmed/25260718?tool=bestpractice.com
Dados retrospectivos de 2010 a 2016 mostraram que a mortalidade intra-hospitalar nos EUA foi maior em mulheres com IAMSSST que em homens (4.8% em comparação com 3.9%, com base em dados não ajustados). Essa diferença na mortalidade permaneceu após os controles para idade, comorbidades e fatores hospitalares.[7]Langabeer JR 2nd, Champagne-Langabeer T, Fowler R, et al. Gender-based outcome differences for emergency department presentation ofnon-STEMI acute coronary syndrome. Am J Emerg Med. 2019 Feb;37(2):179-82.
http://www.ncbi.nlm.nih.gov/pubmed/29754965?tool=bestpractice.com
Estudos mostraram um aumento da incidência de IAMSSST ao longo do tempo.[8]Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000 Dec;36(7):2056-63.
http://www.onlinejacc.org/content/36/7/2056
http://www.ncbi.nlm.nih.gov/pubmed/11127441?tool=bestpractice.com
[9]McManus DD, Gore J, Yarzebski J, et al. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2011 Jan;124(1):40-7.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011975
http://www.ncbi.nlm.nih.gov/pubmed/21187184?tool=bestpractice.com
[10]Roger VL, Weston SA, Gerber Y, et al. Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation. 2010 Feb 23;121(7):863-9.
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.109.897249?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
http://www.ncbi.nlm.nih.gov/pubmed/20142444?tool=bestpractice.com
[11]Rogers WJ, Frederick PD, Stoehr E, et al. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008 Dec;156(6):1026-34.
http://www.ncbi.nlm.nih.gov/pubmed/19032996?tool=bestpractice.com
Provavelmente, isso é consequência do advento de exames mais sensíveis para lesão miocárdica, da farmacoterapia mais precoce e da reperfusão (e prevenção) do IAMCSST.[3]Antman E, Bassand JP, Klein W, et al. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000 Sep;36(3):959-69.
http://www.onlinejacc.org/content/36/3/959
http://www.ncbi.nlm.nih.gov/pubmed/10987628?tool=bestpractice.com
[8]Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000 Dec;36(7):2056-63.
http://www.onlinejacc.org/content/36/7/2056
http://www.ncbi.nlm.nih.gov/pubmed/11127441?tool=bestpractice.com
No entanto, estudos epidemiológicos na Europa relataram reduções nas internações hospitalares por IAMSSST durante a pandemia de COVID-19 (no período de fevereiro-junho de 2020).[12]De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020 Jun 7;41(22):2083-88.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239145
http://www.ncbi.nlm.nih.gov/pubmed/32412631?tool=bestpractice.com
[13]Mesnier J, Cottin Y, Coste P, et al. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study. Lancet Public Health. 2020 Oct;5(10):e536-42.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498416
http://www.ncbi.nlm.nih.gov/pubmed/32950075?tool=bestpractice.com
[14]Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023 Feb 21;147(8):e93-e621.
https://www.ahajournals.org/doi/10.1161/CIR.0000000000001123?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
http://www.ncbi.nlm.nih.gov/pubmed/36695182?tool=bestpractice.com